AKT1 and metabolic dysfunction-associated steatotic liver disease: First, a lack of rescue experiment was performed to verify SSJZF improve hepatic lipid accumulation, hepatic fibrosis, and hepatic function injury in rats with NAFLD model by regulating PI3K/Akt pathway signalling.